Clinical assessment
The clinician confirms the likely pain or function driver and reviews previous investigations and care.
← Longevity Program
Plan optionAct on your priorities
PRF regenerative treatments
An autologous injection option considered selectively after diagnosis, evidence review, and informed consent.
Talk with our team
Plan option
A selective treatment option, not a universal solution.
Platelet-rich fibrin, or PRF, is prepared from a small sample of your own blood. After processing, the platelet- and fibrin-containing material may be injected into a selected area by an appropriately trained clinician.
Whether an injection is reasonable depends on the diagnosis, the body area, available evidence, previous care, and your health history. The expected benefit and quality of evidence can differ substantially between conditions, so suitability is assessed case by case.
What this explores
Useful questions, clearly framed.
The purpose is to support an informed conversation rather than turn one result or service into the whole plan.
- 01
A clear diagnosis and treatment target
- 02
The evidence and alternatives for that specific condition
- 03
Medication, bleeding, infection, and recovery considerations
What to expect
A considered path from question to next step.
Exact timing, providers, and components are confirmed by the MoveWell Med team based on your circumstances.
Informed decision
Potential benefits, uncertainty, costs, alternatives, and risks are discussed before scheduling.
Procedure and follow-up
If appropriate, blood is drawn and processed for the injection, followed by condition-specific aftercare and review.
Part of your longevity plan
Put this service in the right clinical context.
Speak with the MoveWell Med team about your goals, what is appropriate for you, and how this option may fit with the rest of your care.
Start a conversation